Cargando…

Albumin in decompensated cirrhosis: new concepts and perspectives

The pathophysiological background of decompensated cirrhosis is characterised by a systemic proinflammatory and pro-oxidant milieu that plays a major role in the development of multiorgan dysfunction. Such abnormality is mainly due to the systemic spread of bacteria and/or bacterial products from th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bernardi, Mauro, Angeli, Paolo, Claria, Joan, Moreau, Richard, Gines, Pere, Jalan, Rajiv, Caraceni, Paolo, Fernandez, Javier, Gerbes, Alexander L, O'Brien, Alastair J, Trebicka, Jonel, Thevenot, Thierry, Arroyo, Vicente
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Recent Advances in Clinical Practice
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282556/ https://www.ncbi.nlm.nih.gov/pubmed/32102926 http://dx.doi.org/10.1136/gutjnl-2019-318843

Ejemplares similares

Addressing Profiles of Systemic Inflammation Across the Different Clinical Phenotypes of Acutely Decompensated Cirrhosis
por: Trebicka, Jonel, et al.
Publicado: (2019)

The Use of Rifaximin in Patients With Cirrhosis
por: Caraceni, Paolo, et al.
Publicado: (2021)

The cost-effectiveness of albumin in the treatment of decompensated cirrhosis in Germany, Italy, and Spain
por: Runken, M. Chris, et al.
Publicado: (2019)

Correction to: The cost-effectiveness of albumin in the treatment of decompensated cirrhosis in Germany, Italy, and Spain
por: Runken, M. Chris, et al.
Publicado: (2020)

Sympathetic nervous activation, mitochondrial dysfunction and outcome in acutely decompensated cirrhosis: the metabolomic prognostic models (CLIF-C MET)
por: Weiss, Emmanuel, et al.
Publicado: (2023)

Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications
por: Baldassarre, Maurizio, et al.
Publicado: (2021)

Compartmentalization of Immune Response and Microbial Translocation in Decompensated Cirrhosis
por: Alvarez-Silva, Camila, et al.
Publicado: (2019)

Improving Survival in Patients with Decompensated Cirrhosis
por: Amarapurkar, Deepak, et al.
Publicado: (2011)

Acute-on-chronic liver failure: an update
por: Hernaez, Ruben, et al.
Publicado: (2017)

Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated Cirrhosis
por: Pose, Elisa, et al.
Publicado: (2021)

Effective albumin – A novel paradigm in the management of decompensated liver cirrhosis
por: Bernardi, Mauro
Publicado: (2023)

Characterization of Blood Immune Cells in Patients With Decompensated Cirrhosis Including ACLF
por: Weiss, Emmanuel, et al.
Publicado: (2021)

Differential inflammasome activation predisposes to acute-on-chronic liver failure in human and experimental cirrhosis with and without previous decompensation
por: Monteiro, Sofia, et al.
Publicado: (2021)

Targeted Albumin Infusions Do Not Improve Systemic Inflammation or Cardiovascular Function in Decompensated Cirrhosis
por: China, Louise, et al.
Publicado: (2022)

Parenclitic Network Mapping Identifies Response to Targeted Albumin Therapy in Patients Hospitalized With Decompensated Cirrhosis
por: Oyelade, Tope, et al.
Publicado: (2023)

Diagnostic and prognostic significance of cell death markers in patients with cirrhosis and acute decompensation
por: Stoffers, Philipp, et al.
Publicado: (2022)

Copeptin in acute decompensation of liver cirrhosis: relationship with acute-on-chronic liver failure and short-term survival
por: Kerbert, Annarein J. C., et al.
Publicado: (2017)

Antimicrobial prophylaxis in decompensated cirrhosis: friend or foe?
por: Crocombe, Dominic, et al.
Publicado: (2023)

Role of portal venous platelet activation in patients with decompensated cirrhosis and TIPS
por: Queck, Alexander, et al.
Publicado: (2020)

Global hemostatic profiling in patients with decompensated cirrhosis and bacterial infections
por: Zanetto, Alberto, et al.
Publicado: (2022)

Albumin Substitution in Decompensated Liver Cirrhosis: Don’t Forget Zinc
por: Grüngreiff, Kurt, et al.
Publicado: (2021)

Hepatic inflammasome activation as origin of Interleukin-1α and Interleukin-1β in liver cirrhosis
por: Praktiknjo, Michael, et al.
Publicado: (2021)

Sarcopenia Is Associated With Development of Acute-on-Chronic Liver Failure in Decompensated Liver Cirrhosis Receiving Transjugular Intrahepatic Portosystemic Shunt
por: Praktiknjo, Michael, et al.
Publicado: (2019)

Systemic Inflammation and Acute-on-Chronic Liver Failure: Too Much, Not Enough
por: Laleman, Wim, et al.
Publicado: (2018)

Collagen type IV remodelling gender‐specifically predicts mortality in decompensated cirrhosis
por: Lehmann, Jennifer, et al.
Publicado: (2019)

Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy
por: Iwakiri, Yasuko, et al.
Publicado: (2021)

Prediction of nosocomial acute-on-chronic liver failure in patients with cirrhosis admitted to hospital with acute decompensation
por: Zaccherini, Giacomo, et al.
Publicado: (2019)

Severe acute respiratory syndrome (SARS) in children: epidemiology, presentation and management
por: Leung, T.F, et al.
Publicado: (2003)

Applications of dual energy CT in clinical practice: A pictorial essay
por: Sanghavi, Parang S, et al.
Publicado: (2019)

MR-guided focused ultrasound surgery: A novel non-invasive technique in the treatment of adenomyosis –18 month's follow-up of 12 cases
por: Dev, Bhawna, et al.
Publicado: (2019)

Mechanisms of rhinovirus-induced asthma
por: Papadopoulos, Nikolaos G, et al.
Publicado: (2004)

Drug-induced liver injury: recent advances in diagnosis and risk assessment
por: Kullak-Ublick, Gerd A, et al.
Publicado: (2017)

Albumin Homodimers in Patients with Cirrhosis: Clinical and Prognostic Relevance of a Novel Identified Structural Alteration of the Molecule
por: Baldassarre, Maurizio, et al.
Publicado: (2016)

Use of albumin infusion for cirrhosis-related complications: An international position statement
por: Bai, Zhaohui, et al.
Publicado: (2023)

Prevention of Cirrhosis Complications: Looking for Potential Disease Modifying Agents
por: Zaccherini, Giacomo, et al.
Publicado: (2021)

The significance of C-reactive protein to albumin ratio in patients with decompensated cirrhosis
por: Oikonomou, Theodora, et al.
Publicado: (2020)

Prognostic value of albumin‐related ratios in HBV‐associated decompensated cirrhosis
por: Zhang, Tan, et al.
Publicado: (2022)

Prognostic value of neutrophil count to albumin ratio in patients with decompensated cirrhosis
por: Yao, Junjie, et al.
Publicado: (2023)

Future therapy of portal hypertension in liver cirrhosis – a guess
por: Sauerbruch, Tilman, et al.
Publicado: (2014)

Managing portal hypertension in patients with liver cirrhosis
por: Sauerbruch, Tilman, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_aerouqjqp9u8mlrk7a71493n5t